Release Date: 06/11/09 15:34 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 33.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%